angiotensin ii has been researched along with Hyperuricemia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HH; Hsieh, SM; Lin, DP; Pai, HL; Su, YS; Sue, XY | 1 |
| Huang, PH; Lin, SJ; Tsai, HY; Tsai, SH; Wang, JC | 1 |
| Borgi, L; Curhan, G; Fisher, N; Forman, J; McMullan, CJ | 1 |
| Kuroczycka-Saniutycz, E; Milewski, R; Sulik, A; Wasilewska, A | 1 |
| Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R | 1 |
| Çetin, A; Kırça, M; Oğuz, N; Uzuner, F; Yeşilkaya, A | 1 |
| Avila-Casado, C; Franco, M; Johnson, RJ; Nakagawa, T; Rodríguez-Iturbe, B; Sánchez-Lozada, LG; Sautin, YY; Soto, V; Tapia, E | 1 |
| Chen, K; Cui, WY; Liu, GS; Long, CL; Pan, ZY; Qin, XC; Wang, H; Zhang, YF | 1 |
| Chen, J; Cheng, M; Ding, X; Han, F; Le, Y; Xu, L; Zhang, L; Zhu, X | 1 |
| Day, RO; Graham, GG; Indraratna, PL; Williams, KM | 1 |
| Sidorenko, BA; Ugriumova, MO | 1 |
| Brown, NJ; Fisher, ND; Gumieniak, O; Hollenberg, NK; Hopkins, PN; Murphey, LJ; Perlstein, TS; Williams, GH | 1 |
| Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M | 1 |
1 review(s) available for angiotensin ii and Hyperuricemia
| Article | Year |
|---|---|
[New perspectives of the use of angiotensin II receptor blocker].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Hyperuricemia; Losartan; Receptors, Angiotensin | 2003 |
3 trial(s) available for angiotensin ii and Hyperuricemia
| Article | Year |
|---|---|
Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
Topics: Adult; Allopurinol; Angiotensin II; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Boston; Double-Blind Method; Down-Regulation; Female; Humans; Hyperuricemia; Kidney; Male; Middle Aged; Probenecid; Renin; Renin-Angiotensin System; Time Factors; Treatment Outcome; Uric Acid; Uricosuric Agents; Young Adult | 2017 |
Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
Topics: Allografts; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Chronic Disease; Creatinine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Nephritis, Interstitial; Treatment Outcome; Uric Acid | 2014 |
Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Case-Control Studies; Cyclosporine; Female; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Losartan; Male; Middle Aged; Polycythemia; Prospective Studies; Receptor, Angiotensin, Type 1; Safety; Uric Acid | 2009 |
9 other study(ies) available for angiotensin ii and Hyperuricemia
| Article | Year |
|---|---|
Short-Term Hyperuricemia Leads to Structural Retinal Changes That Can be Reversed by Serum Uric Acid Lowering Agents in Mice.
Topics: Allopurinol; Angiotensin II; Animals; Benzbromarone; Hyperuricemia; Macular Degeneration; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred ICR; Uric Acid | 2022 |
Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1/ERK/MMP-9 signaling pathway.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; Humans; Hyperuricemia; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Reactive Oxygen Species; Retrospective Studies; Signal Transduction; Uric Acid | 2023 |
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension.
Topics: Adolescent; Angiotensin II; Angiotensinogen; Biomarkers; Body Mass Index; Chi-Square Distribution; Child; Creatinine; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Hyperuricemia; Kidney; Linear Models; Lipids; Male; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Up-Regulation; Uric Acid | 2013 |
Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ.
Topics: Angiotensin II; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Proliferation; Gene Expression Regulation; Humans; Hypertension; Hyperuricemia; Losartan; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; Receptor, Platelet-Derived Growth Factor beta; Uric Acid | 2017 |
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
Topics: Aldehydes; Angiotensin II; Animals; Antioxidants; Arterioles; Body Weight; Cyclic N-Oxides; Disease Models, Animal; Glomerular Filtration Rate; Hypertension, Renal; Hyperuricemia; Kidney Glomerulus; Male; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Oxonic Acid; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Superoxides; Tyrosine | 2008 |
Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Angiotensins; Animals; Cells, Cultured; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Hypertension; Hyperuricemia; KATP Channels; Kidney; Kidney Diseases; Male; Nitric Oxide; Oxonic Acid; Propylamines; Rats; Rats, Sprague-Dawley; Urate Oxidase; Uric Acid; Xanthine Oxidase | 2008 |
Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Obesity; Renin-Angiotensin System; Risk Factors; Uric Acid | 2009 |
Uric acid and the state of the intrarenal renin-angiotensin system in humans.
Topics: Adult; Angiotensin II; Blood Pressure; Female; Humans; Hypertension, Renal; Hyperuricemia; Kidney; Male; Middle Aged; Predictive Value of Tests; Renal Circulation; Renin-Angiotensin System; Risk Factors; Uric Acid | 2004 |
The CARI guidelines. Prevention of progression of kidney disease.
Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy | 2006 |